hey, I am trying to add, too, but where is the line drawn
if and when a government agency declares your company a candidate for a sickle cell drug, through the means of a
public statement.
I don't see XKEM management denying this stmt made from that article.
I call that an 8-K event.
IMHO, there are some onfilled obligations here.
XKEM filed that 8-K from the Bristol Meyers Squib settlement money and how some of it was disbursed.